1-ethyl-2-benzimidazolinone has been researched along with dinoprostone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halm, DR; Halm, ST; Liao, T | 1 |
Bradding, P; Brightling, CE; Cockerill, SL; Cruse, G; Duffy, SM | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and dinoprostone
Article | Year |
---|---|
Distinct K+ conductive pathways are required for Cl- and K+ secretion across distal colonic epithelium.
Topics: Animals; Benzimidazoles; Carbachol; Chlorides; Cholinergic Agonists; Colon; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Electric Conductivity; Female; Guinea Pigs; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Male; Osmolar Concentration; Potassium; Potassium Channel Blockers; Potassium Channels; Pyrazoles; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2006 |
Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.
Topics: Alprostadil; Benzimidazoles; Calcium Channel Agonists; Cell Movement; Chemotaxis; Dinoprostone; Histamine Release; Humans; Mast Cells; Potassium Channels; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Xanthones | 2008 |